Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics - Top-Institutions - MDSpire

Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics

  • By

  • Mingcong Chen

  • Xiang Wang

  • Gang Peng

  • Lihe Jiang

  • Hao Liang

  • Ping Cui

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Neurosurgery

  • #2

    University Medical Center Hamburg-Eppendorf
    University Medical Center Hamburg-Eppendorf

    Hamburg, Germany

    Key Differentiators

    • Oncology

  • #3

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Neurosurgery

  • #4

    Dusseldorf Central Nervous System Tumor Tissue Bank
    Dusseldorf Central Nervous System Tumor Tissue Bank

    Dusseldorf, Germany

    Key Differentiators

    • Oncology

  • #5

    Center for Stem Cell and Translational Immunotherapy
    Center for Stem Cell and Translational Immunotherapy

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Stem Cell Research

Original Source(s)

Gut microbiota induces immune-related alterations in gene expression, RNA methylation, and metabolism in glioblastoma revealed by single-cell and spatial multi-omics

  • by Mingcong Chen, Xiang Wang, Gang Peng, Lihe Jiang, Hao Liang, Ping Cui

  • July 15, 2026

Related Content

Sarcopenia in breast cancer: prognostic values and emerging therapeutic strategies

Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations

Proteomics and transcriptomics reveal molecular subtypes and biomarkers of advanced cutaneous T-cell lymphoma